Company |
Amount raised |
Sinopharm Group Co. (China) |
$700M |
Jazz Pharmaceuticals plc (Dublin) |
$500M |
PDL Biopharma Inc. (Incline Village, Nev.) |
$300M |
Aegerion Pharmaceuticals (Cambridge, Mass.) |
$300M |
Isis Pharmaceuticals Inc. (Carlsbad, Calif.) |
$285M |
Alkermes plc (Dublin) |
$250M |
Emergent Biosolutions Inc. (Rockville, Md.) |
$250M |
Clovis Oncology Inc. (Boulder, Colo.) |
$237M |
Depomed Inc. (Newark, Calif.) |
$230M |
Ligand Pharmaceuticals Inc. (San Diego) |
$225M |
Ariad Pharmaceuticals Inc. (Cambridge, Mass.) |
$200M |
Synergy Pharmaceuticals Inc. (New York) |
$200M |
Skyepharma plc (London) |
$186.5M |